The Relative Strength (RS) Rating for InMode moved into a new percentile Monday, as it got a lift from 66 to 73.
IBD's proprietary RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history shows that the market's biggest winners typically have an 80 or better RS Rating in the early stages of their moves. See if InMode can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While InMode is not near an ideal entry right now, see if it is able to form and break out of a proper consolidation.
The company reported negative growth for both sales and earnings last quarter.
The company holds the No. 10 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, iRadimed and Masimo are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
